← back to search

Yi‐Xin Zeng

Sun Yat-sen University · CN
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Viral-associated cancers and disorders, RNA modifications and cancer, Cancer-related molecular mechanisms research, and Head and Neck Cancer Studies.
h-index
56
citations
10,545
works
375
NIH funding
primary concept
email

Recent publications

EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
Nature 2026cited by 2position: middledoi
R9AP is a common receptor for EBV infection in epithelial cells and B cells
Nature 2025cited by 15position: middledoi
Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma
Cancer Cell 2025cited by 13position: middledoi
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
Nature Communications 2024cited by 25position: middledoi
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial
Journal of Clinical Oncology 2024cited by 24position: middledoi
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation
Cell Genomics 2024cited by 23position: middledoi
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Cell Host & Microbe 2023cited by 66position: middledoi
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
Trends in Microbiology 2023cited by 36position: middledoi
Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopes
Emerging Microbes & Infections 2023cited by 17position: middledoi
Data from Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma Antigen
2023cited by 0position: lastdoi
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
npj Vaccines 2022cited by 81position: middledoi
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
Proceedings of the National Academy of Sciences 2022cited by 59position: middledoi
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
Nature Communications 2022cited by 50position: middledoi
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
Nature Communications 2021cited by 284position: middledoi
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
ACS Nano 2021cited by 233position: middledoi
DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis
Nature Communications 2021cited by 232position: middledoi
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes
Signal Transduction and Targeted Therapy 2021cited by 134position: middledoi
N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
EMBO Reports 2021cited by 104position: middledoi
A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma
Nature Communications 2021cited by 52position: middledoi
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
Nature Communications 2020cited by 157position: middledoi
Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy
Journal of the American Society of Nephrology 2020cited by 64position: middledoi
Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
Nature Cell Biology 2020cited by 57position: middledoi
Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
Nature Genetics 2019cited by 234position: middledoi
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Proceedings of the National Academy of Sciences 2019cited by 177position: middledoi
STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
Cell Death and Differentiation 2019cited by 128position: middledoi
Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
Theranostics 2019cited by 81position: middledoi
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of <i>ATRX</i> -Mutant Cancers to WEE1 Inhibition
Cancer Research 2019cited by 74position: middledoi
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations
The Lancet Oncology 2019cited by 70position: middledoi
Prognostic implications of a molecular classifier derived from whole‐exome sequencing in nasopharyngeal carcinoma
Cancer Medicine 2019cited by 29position: middledoi
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer
Gastroenterology 2018cited by 175position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mu‐Sheng Zeng · Sun Yat-sen University14 papers (2012–2025)Miao Xu · Sun Yat-sen University10 papers (2013–2025)Qi-Sheng Feng · Sun Yat-sen University10 papers (2012–2024)Wei‐Hua Jia · Sun Yat-sen University9 papers (2012–2023)Tiebang Kang · Sun Yat-sen University9 papers (2012–2021)Jin‐Xin Bei · Sun Yat-sen University8 papers (2012–2021)Xiao‐Feng Zhu · Shandong University of Traditional Chinese Medicine7 papers (2012–2017)Jia He · Service de Santé des Armées7 papers (2013–2019)Su‐Mei Cao · Sun Yat-sen University7 papers (2014–2025)Shu-bio Ye · Sun Yat-sen University6 papers (2014–2019)Weimin Ye · Fujian Medical University6 papers (2012–2021)Shang‐Hang Xie · Sun Yat-sen University6 papers (2014–2025)Chao‐Nan Qian · Sun Yat-sen University6 papers (2012–2018)Xiao-Shuai Zhang · South China Normal University6 papers (2014–2019)Jiang Li · Chengdu University of Technology5 papers (2014–2019)Zhe Zhang · Tulane University5 papers (2016–2021)Zhiwei Liu · Tianjin University of Science and Technology5 papers (2014–2024)Jian‐Yong Shao · Sun Yat-sen University5 papers (2012–2019)Dan Xie · Capital Medical University5 papers (2012–2015)Ellen T. Chang · Amgen (United States)4 papers (2016–2021)